Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Meningococcal Disease Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Meningococcal Disease Drugsmarket, defines the market attractiveness level of Meningococcal Disease Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Meningococcal Disease Drugs industry, describes the types of Meningococcal Disease Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Meningococcal Disease Drugs market and the development prospects and opportunities of Meningococcal Disease Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Meningococcal Disease Drugs market in Chapter 13.
By Player:
Pfizer
GlaxoSmithKline
Sanofi Pasteur
Novartis
By Type:
Injectable
Oral
By End-User:
Hospitals
Drugstores
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Meningococcal Disease Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Meningococcal Disease Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Meningococcal Disease Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Meningococcal Disease Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Meningococcal Disease Drugs Market Analysis and Outlook to 2022
-
7.1 Global Meningococcal Disease Drugs Consumption (2017-2022)
-
7.2 United States Meningococcal Disease Drugs Consumption (2017-2022)
-
7.3 Europe Meningococcal Disease Drugs Consumption (2017-2022)
-
7.4 China Meningococcal Disease Drugs Consumption (2017-2022)
-
7.5 Japan Meningococcal Disease Drugs Consumption (2017-2022)
-
7.6 India Meningococcal Disease Drugs Consumption (2017-2022)
-
7.7 South Korea Meningococcal Disease Drugs Consumption (2017-2022)
8 Region and Country-wise Meningococcal Disease Drugs Market Analysis and Outlook to 2028
-
8.1 Global Meningococcal Disease Drugs Consumption Forecast (2022-2028)
-
8.2 United States Meningococcal Disease Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Meningococcal Disease Drugs Consumption Forecast (2022-2028)
-
8.4 China Meningococcal Disease Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Meningococcal Disease Drugs Consumption Forecast (2022-2028)
-
8.6 India Meningococcal Disease Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Meningococcal Disease Drugs Consumption Forecast (2022-2028)
9 Global Meningococcal Disease Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Meningococcal Disease Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Injectable Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Oral Consumption and Growth Rate (2017-2022)
-
9.2 Global Meningococcal Disease Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Drugstores Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Meningococcal Disease Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Meningococcal Disease Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Injectable Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Meningococcal Disease Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Drugstores Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Meningococcal Disease Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Meningococcal Disease Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Meningococcal Disease Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Meningococcal Disease Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Meningococcal Disease Drugs Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Meningococcal Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Meningococcal Disease Drugs Product and Service
-
14.2 GlaxoSmithKline
-
14.2.1 GlaxoSmithKline Company Details
-
14.2.2 GlaxoSmithKline Meningococcal Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GlaxoSmithKline Meningococcal Disease Drugs Product and Service
-
14.3 Sanofi Pasteur
-
14.3.1 Sanofi Pasteur Company Details
-
14.3.2 Sanofi Pasteur Meningococcal Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sanofi Pasteur Meningococcal Disease Drugs Product and Service
-
14.4 Novartis
-
14.4.1 Novartis Company Details
-
14.4.2 Novartis Meningococcal Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novartis Meningococcal Disease Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Meningococcal Disease Drugs
-
Figure Meningococcal Disease Drugs Picture
-
Table Global Meningococcal Disease Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Meningococcal Disease Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Meningococcal Disease Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Meningococcal Disease Drugs Consumption by Country (2017-2022)
-
Figure United States Meningococcal Disease Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Meningococcal Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Meningococcal Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Meningococcal Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Meningococcal Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Meningococcal Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Meningococcal Disease Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Meningococcal Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Meningococcal Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Meningococcal Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Meningococcal Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Meningococcal Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Meningococcal Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injectable Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Drugstores Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Injectable Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugstores Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Meningococcal Disease Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Meningococcal Disease Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Meningococcal Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Meningococcal Disease Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Meningococcal Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Meningococcal Disease Drugs Product and Service
-
Table Sanofi Pasteur (Foundation Year, Company Profile and etc.)
-
Table Sanofi Pasteur Meningococcal Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Pasteur Meningococcal Disease Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Meningococcal Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Meningococcal Disease Drugs Product and Service
-
